Business · 30/09/2021Updated: 10/17/2026 · 1 min read
FDA Announces Fee Rates for Tropical Disease Priority Review Vouchers for FY 2022
Summary
The Food and Drug Administration (FDA) has set the fee rates for using a tropical disease priority review voucher for the fiscal year 2022, as mandated by the Federal Food, Drug, and Cosmetic Act (FD&C Act) and the Food and Drug Administration Amendments Act of 2007 (FDAAA).
Original source language: Federal Register — Food and Drug AdministrationOpen original release →